Pearlman Cancer Center at South Georgia Medical Center

The Pearlman Comprehensive Cancer Center at South Georgia Medical Center (SGMC) is a cancer center located in Valdosta, Georgia. The center is accredited by the American College of Surgeons Commission on Cancer as a Community Hospital Comprehensive Cancer Program. The center is also accredited by the American College of Radiology (ACR). There are five physicians at the center. The Radiation Oncology program at SGMC is one of seven in Georgia accredited by the American College of Radiology. The center offers stereotactic radiotherapy, clinical trials, cancer survivorship program, prevention, nutrition, screening recommendations and treatment. Pearlman Cancer Center's comprehensive, multidisciplinary approach to care that includes the medical, nutritional, spiritual, educational and psychosocial needs of patients.

Treatment Sites in Georgia

Primary Location

2501 North Patterson Street
Valdosta, GA 31602
229-259-4600 (p)
www.sgmc.org

driving directions

Clinical Trials in Georgia

A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy vs. Observation in Patients with Residual Triple-Negative Basal-like Breast Cancer following Neoadjuvant Chemotherapy
Cancer Type: Breast Cancer

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with = 1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) after Neoadjuvant Chemotherapy
Cancer Type: Breast Cancer

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Cancer Type: Lung Cancer

LUX-Lung EAP US; An Open Label Expanded Access Program of Afatinib (BIBW 2992) for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
Cancer Type: Lung Cancer

Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer
Cancer Type: Breast Cancer

Phase III Randomized Study of Standard Adjuvant Endocrine Therapy With Versus Without Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive, and HER2-Negative Breast Cancer
Cancer Type: Breast Cancer

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Cancer Type: Breast Cancer

S1400 Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
Cancer Type: Lung Cancer